The guidance encourages the use of Bayesian statistics in drug trials. Instead of starting from scratch and only adding new ...
Ideally, specific treatment for a cancer patient is decided by a multidisciplinary tumor board, integrating prior clinical experience, published data, and patient-specific factors to develop a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results